Covidien plc

Covidien — Merger or Acquisition (August 2014)

21 slides from Covidien's merger presentation, Aug 22, 2014

  1. Slide 1: Global Town Hall Meeting with Chairman and CEO Omar Ishrak

    Global Town Hall Meeting with Chairman and CEO Omar Ishrak August 22, 2014

  2. Slide 2: Medtronic to Acquire Covidien

    Medtronic to Acquire Covidien

  3. Slide 3: The Medtronic Mission: A Shared Sense of Purpose

    The Medtronic Mission: A Shared Sense of Purpose “ To contribute to human welfare…alleviate pain, restore health, and extend life… To direct our growth in the areas of maximum strength and ability…to continuously build on these areas through education and knowledge… To strive without reserve for the

  4. Slide 4: Combination Results in Strategic Diversification

    Combination Results in Strate ication Surgical Solutions Spine Respiratory & Diabetes Patient Care Cardiac Rhythm & Heart Failure Cor Structu

  5. Slide 5: A Strong Strategic Fit

    A Strong Strategic Fit Uniquely positioned to expand our industry-leading franchises through our three differentiated strategies: Therapy Innovation: Delivering strong launch cadence of meaningful therapies & and procedures Globalization: Addressing the inequities in healthcare access globally Econo

  6. Slide 6: Three Key Benefits for Medtronic and Covidien

    Three Key Benefits for Medtronic and Covidien Therapy Innovation 1. Strengthen and enhance Peripheral Vascular and Neuroscience portfolios 2. Leverage adjacencies in Medtronic Surgical Technologies and Covidien Surgical Solutions Therapy Innovation 3. Accelerate market adoption of early stage Covidi

  7. Slide 7: Combined Company Immediately Accelerates Ability to Expand Global Access

    Combined Company Immediately Accelerates Ability to Expand Global Access 150+ 300+ $3.7B ombined ies ons revenue ü Broader presence facilitates more rapid expansion ü Covidien products such as surgical tools and capital equipment are adopted earlier in hospitals, becoming a base for Medtronic chroni

  8. Slide 8: Complementary Solutions Create Opportunities for Robust Integrated Health Offerings

    Complementary Solutions Create Opportunities for Robust Integrated Health Offerings Value in hospita efficiencies Value in po acute setting

  9. Slide 9: Integration Update

    Integration, Update

  10. Slide 10: Integration Update – Geoff Martha, SVP and Chief Integration Officer

    Integration Update Geoff Martha SVP and Chief Integration Officer

  11. Slide 11: Covidien Integration: Strategy for Success

    Covidien Integration: Strategy for Success PRESERVE Achieve MDT & COV Strategic Plans Protect the front end Maintain business momentum at both companies Change vs. disruption Cost Reduction OPTIMIZE Rigorous execution vs. stretch targets Exceed our announced synergy targets and reinvest Optimized se

  12. Slide 12: Integration Architecture Is In Place

    Integration Architecture Is In Place Joint Steering Committee Medtronic Covidien Omar Ishrak Joe Almeida (CEO) Gary Ellis Bryan Hanson (EVP, Group Leader) Carol Surface Chuck Dockendorff (CFO) Mike Dunford (HR Leader) Core IMO leaders Extended IMO Geoff Martha and Bill Burke (COV) Advisory team to C

  13. Slide 13: InSite: News and Perspective on the Covidien Integration

    InSite: News and Perspective on the Covidien Integration Go to the Covidien Acquisition Tab on myMedtronic to learn more

  14. Slide 14: Combined Impact

    Combined Impact

  15. Slide 15: Further Expanding Our Comprehensive Portfolio

    Further Expanding Our Comprehensive Portfolio Neurological Ear, nose and throat Severe spasticity Sinus diseases Parkinson’s disease Structur hm Thyroid conditions Essential tremor Heart valve illation Otologic disorders Dystonia* Congenital t rates Sleep-disordered breathing Hydrocephalus dia) Pedi

  16. Slide 16: Transforming Healthcare Around the World: $27 Billion Healthcare Leader

    Transforming Healthcare Around the World to Improve More Lives Together: $27 Billion Healthcare Leader 87,000+ Employees Life-Changing Impact for Millions of Patients Every 3seconds

  17. Slide 17: Global Town Hall Meeting with Chairman and CEO Omar Ishrak

    Global Town Hall Meeting with Chairman and CEO Omar Ishrak August 22, 2014

  18. Slide 18: Disclaimers

    Disclaimers NO OFFER OR SOLICITATION This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pur

  19. Slide 19: Disclaimers (cont'd)

    Disclaimers (cont’d) PARTICIPANTS IN THE SOLICITATION Medtronic, New Medtronic and Covidien and certain of their respective directors and executive officers and employees may be considered participants in the solicitation of proxies from the respective shareholders of Medtronic and Covidien in respe

  20. Slide 20: Disclaimers (cont'd): Cautionary Statement Regarding Forward-Looking Statements

    Disclaimers (cont’d) Cautionary Statement Regarding Forward-Looking Statements Statements contained in this communication that refer to New Medtronic’s, Medtronic’s and/or Covidien’s estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-loo

  21. Slide 21: Disclaimers (cont'd): Statement Required by the Irish Takeover Rules

    Disclaimers (cont’d) Statement Required by the Irish Takeover Rules The directors of Medtronic accept responsibility for the information contained in this document. To the best of the knowledge and belief of the directors of Medtronic (who have taken all reasonable care to ensure that such is the ca

Covidien — Merger or Acquisition (August 2014) on 6ix